GLP-1 receptor agonist toxicity: Difference between revisions

Line 6: Line 6:


==Clinical Features==
==Clinical Features==
 
Similar to side effects normally associated with these medications, but worse:
*[[Nausea/vomiting]]
*[[Constipation]]
*[[Epigastric pain]]
*[[Headache]]
*[[Tachycardia]]
*Sweating
*[[Confusion]]
*[[Delirium]]


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 20:29, 31 January 2024

Background

  • GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
    • Semaglutide
    • Liraglutide
  • Poison control centers have reported increasing inquiries related to possible overdoses

Clinical Features

Similar to side effects normally associated with these medications, but worse:

Differential Diagnosis

Nausea and vomiting

Critical

Emergent

Nonemergent

Evaluation

Workup

Diagnosis

Management

  • Symptomatic management
    • Anti-nausa medications (e.g., zofran)
  • Consider stopping other glucose-lowering (i.e, diabetic) medications

Disposition

See Also

External Links

References